Cargando…
Sodium-glucose co-transporter-2 inhibitor mediated cardio-protection: does increase of hematocrit finally matter? Sub-analysis of a prospective, observational study
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278171/ https://www.ncbi.nlm.nih.gov/pubmed/35846411 http://dx.doi.org/10.5114/amsad.2022.116665 |
_version_ | 1784746141473046528 |
---|---|
author | Patoulias, Dimitrios Papadopoulos, Christodoulos Karagiannis, Asterios Doumas, Michael |
author_facet | Patoulias, Dimitrios Papadopoulos, Christodoulos Karagiannis, Asterios Doumas, Michael |
author_sort | Patoulias, Dimitrios |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9278171 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-92781712022-07-15 Sodium-glucose co-transporter-2 inhibitor mediated cardio-protection: does increase of hematocrit finally matter? Sub-analysis of a prospective, observational study Patoulias, Dimitrios Papadopoulos, Christodoulos Karagiannis, Asterios Doumas, Michael Arch Med Sci Atheroscler Dis Letter to the Editor Termedia Publishing House 2022-07-07 /pmc/articles/PMC9278171/ /pubmed/35846411 http://dx.doi.org/10.5114/amsad.2022.116665 Text en Copyright: © 2022 Termedia & Banach https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
spellingShingle | Letter to the Editor Patoulias, Dimitrios Papadopoulos, Christodoulos Karagiannis, Asterios Doumas, Michael Sodium-glucose co-transporter-2 inhibitor mediated cardio-protection: does increase of hematocrit finally matter? Sub-analysis of a prospective, observational study |
title | Sodium-glucose co-transporter-2 inhibitor mediated cardio-protection: does increase of hematocrit finally matter? Sub-analysis of a prospective, observational study |
title_full | Sodium-glucose co-transporter-2 inhibitor mediated cardio-protection: does increase of hematocrit finally matter? Sub-analysis of a prospective, observational study |
title_fullStr | Sodium-glucose co-transporter-2 inhibitor mediated cardio-protection: does increase of hematocrit finally matter? Sub-analysis of a prospective, observational study |
title_full_unstemmed | Sodium-glucose co-transporter-2 inhibitor mediated cardio-protection: does increase of hematocrit finally matter? Sub-analysis of a prospective, observational study |
title_short | Sodium-glucose co-transporter-2 inhibitor mediated cardio-protection: does increase of hematocrit finally matter? Sub-analysis of a prospective, observational study |
title_sort | sodium-glucose co-transporter-2 inhibitor mediated cardio-protection: does increase of hematocrit finally matter? sub-analysis of a prospective, observational study |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278171/ https://www.ncbi.nlm.nih.gov/pubmed/35846411 http://dx.doi.org/10.5114/amsad.2022.116665 |
work_keys_str_mv | AT patouliasdimitrios sodiumglucosecotransporter2inhibitormediatedcardioprotectiondoesincreaseofhematocritfinallymattersubanalysisofaprospectiveobservationalstudy AT papadopouloschristodoulos sodiumglucosecotransporter2inhibitormediatedcardioprotectiondoesincreaseofhematocritfinallymattersubanalysisofaprospectiveobservationalstudy AT karagiannisasterios sodiumglucosecotransporter2inhibitormediatedcardioprotectiondoesincreaseofhematocritfinallymattersubanalysisofaprospectiveobservationalstudy AT doumasmichael sodiumglucosecotransporter2inhibitormediatedcardioprotectiondoesincreaseofhematocritfinallymattersubanalysisofaprospectiveobservationalstudy |